Arrhythmias & electrophysiology

Long-term outcomes of subcutaneous versus transvenous implantable cardioverter defibrillator use among patients on maintenance dialysis

Heart RhythmPublished Retrospective cohort study

Main finding · DeathResult — go to the resultHazard ratio 1.12 95% CI 0.96–1.30

Authors' conclusion

In this representative longitudinal cohort study of dialysis patients, compared with TV-ICD, S-ICD was not associated with decreased risks of death, hospitalization, device complications, or dialysis access interventions.

Study context

Population
Fee-For-Service Medicare beneficiary dialysis patients receiving an ICD, National Cardiovascular Data Registry ICD Registry
Participants
529 vs 842
Exposure
S-ICD vs single-chamber TV-ICD
  • S-ICDn = 529
  • TV-ICDn = 842reference
Outcome
Death
Methodological detailsstabilized inverse probability of treatment weighting
  • Stabilized inverse probability of treatment weighting

Main finding

As reported in the abstract

Hazard ratio

1.12

95% CI 0.96–1.30

S-ICDvs TV-ICD
HR 1.12 (95% CI 0.96–1.30)

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Hospital admission1.01 (0.88–1.16)
Subsequent dialysis access interventions1.12 (0.86–1.46)

Safety

OutcomeHR (95% CI)
Bacteremia or sepsis1.01 (0.80–1.26)
Device reoperation1.06 (0.59–1.89)

Original publication

Long-term outcomes of subcutaneous versus transvenous implantable cardioverter defibrillator use among patients on maintenance dialysis. Heart Rhythm. Published 28 November 2024. doi:10.1016/j.hrthm.2024.11.050

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.